Haven't used Micromet yet?
Ask Trustburn

Ask Trustburn about Micromet

Based on 8 reviews on Trustburn

Based on reviews on this page. Verify anything important with the company directly.

Michael Albright
Reviews 1

I recently visited cancervax.com and found it to be quite informative. The content was well-presented, and it was easy to navigate through the pages. However, there is room for improvement in terms of design. The company seems reliable and trustworthy.

Rosemary Giovannelli
Reviews 1

👍 I am impressed with Micromet's website at cancervax.com. The layout is clean and intuitive. The information provided is comprehensive and up-to-date. It's a valuable resource for anyone interested in cancer research. Well done, Micromet! 👏

Sarah Guptill
Reviews 1

Micromet is an average company, but their website cancervax.com is surprisingly comprehensive. It covers a wide range of topics related to cancer research and treatment. It's worth checking out if you're interested in the field.

Edward Willis
Reviews 1

Micromet is an average company, but their website cancervax.com offers valuable information. It covers various aspects of cancer research and provides helpful resources. It's definitely worth checking out if you're interested in the field.

Questions & Answers

No questions yet — be the first to ask.

News & Press

No news yet. This is where the business shares its own updates and press.

Photos

No photos yet. Photos shared by reviewers will show up here.

Widgets

Boost your business trust by displaying widget on your website — its a simple way to convert your visitors into customers.

Embed code

<script src="https://trustburn.com/widgets/index.js"></script>
<div class="trustburn-widget" data-trustburn-protocol="https:" data-trustburn-domain="trustburn.com" data-trustburn-widget="score" data-company-path="cancervax-com" data-lang="en"></div>
More widgets

About Micromet

Micromet is a biotechnology company focused on the research, development and commercialization of novel biological products for the treatment and control of cancer. Their lead product candidate, Canvaxin, is one of a new class of products being developed in the area of specific active immunotherapy, also known as therapeutic cancer vaccines.